ARTIDIS

ARTIDIS, based on nano-cancer biomarkers, enables rapid cancer diagnosis, detects its invasiveness, and predicts the likelihood of metastasis in patients. The ARTIDISNET platform integrates nanomechanical biomarkers with patients' clinical data to guide the optimal treatment choice for each patient.